MetLife Investment Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

MetLife Investment Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,080	Closed	-$506K	–	2860
2022 Q4	$506K	Sell	14,080 -4,246	-23%	-$106K	﹤0.01%	1639
2022 Q3	$276K	Buy	18,326 +5,756	+46%	+$93.4K	﹤0.01%	2083
2022 Q2	$168K	Hold	12,570	–	–	﹤0.01%	2434
2022 Q1	$242K	Buy	+12,570	New	+$261K	﹤0.01%	2241

MetLife Investment Management's IMGO Position: Q1 2023 in Review

MetLife Investment Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 14,080 shares — an estimated $506K sold.

MetLife Investment Management first reported a position in IMGO in Q1 2022 and held it in 4 quarters. The position peaked at $506K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

MetLife Investment Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
MetLife Investment Management sold 14,080 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $506K.
MetLife Investment Management first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 4 quarters.
MetLife Investment Management's Imago BioSciences, Inc. Common stock position peaked at $506K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.